Nephrosの空売り状況は、投資家がNephrosの株価下落に賭けている度合いを知ることができます。空売りデータは2週間ごとに更新されます。

Nephros (NASDAQ:NEPH) 株価情報, 空売り情報

Nephros

Nephros Inc is a commercial-stage company that develops and sells high-performance water solutions to the medical and commercial markets. In medical markets, it sells water filtration products and waterborne pathogen detection products. In commercial markets, the company manufactures and sells water filters that improve the taste and odor of water and reduce biofilm, bacteria, and scale build-up in downstream equipment. The company's subsidiary is engaged in the development of its second-generation hemodiafiltration system and other products focused on improving therapies for patients with renal disease. The company generates almost all of its revenue from product sales and a small amount from royalty revenue and other revenues.

Nephros Inc

<h3>Gainers</h3>
<ul>
<li>Zeo Energy (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ZEO#NASDAQ">ZEO</a>) shares increased by 89.9% to $3.0 during Thursday's regular session. The market value of their outstanding shares is at $42.0 million. As per the press release, Q4 earnings came out 2 days ago. </li>
<li>Webus International (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/WETO#NASDAQ">WETO</a>) shares increased by 47.95% to $2.9. The company's market cap stands at $63.8 million. </li>
<li>Servotronics (AMEX:<a class="ticker" href="https://www.benzinga.com/stock/SVT#AMEX">SVT</a>) shares rose 23.11% to $46.65. The market value of their outstanding shares is at $119.2 million. </li>
<li>CDT Envirn Tech Inv Hldgs (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CDTG#NASDAQ">CDTG</a>) stock rose 15.16% to $0.68. The market value of their outstanding shares is at $8.3 million. </li>
<li>Captivision (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CAPT#NASDAQ">CAPT</a>) shares rose 14.2% to $0.72. The market value of their outstanding shares is at $23.6 million. </li>
<li>Singularity Future Tech (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SGLY#NASDAQ">SGLY</a>) stock increased by 12.73% to $0.98. The market value of their outstanding shares is at $4.1 million. </li>
</ul>
<h3>Losers</h3>
<ul>
<li>Elong Power Holding (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ELPW#NASDAQ">ELPW</a>) stock decreased by 57.7% to $1.48 during Thursday's regular session. The company's market cap stands at $74.0 million. </li>
<li>Pinnacle Food Group (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PFAI#NASDAQ">PFAI</a>) shares declined by 28.3% to $1.85. The market value of their outstanding shares is at $21.6 million. </li>
<li>ESS Tech (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/GWH#NYSE">GWH</a>) shares fell 22.53% to $0.86. The company's market cap stands at $10.4 million. </li>
<li>Eos Energy Enterprises (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/EOSE#NASDAQ">EOSE</a>) shares fell 17.65% to $4.94. The company's market cap stands at $1.1 billion. </li>
<li>Highway Holdings (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/HIHO#NASDAQ">HIHO</a>) shares fell 15.35% to $1.49. The company's market cap stands at $6.5 million. </li>
<li>Nephros (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NEPH#NASDAQ">NEPH</a>) stock decreased by 11.37% to $2.59. The market value of their outstanding shares is at $27.4 million. 
See Also: <a href="http://www.benzinga.com/money/best-industrials-stocks/" title="www.benzinga.com/money/best-industrials-stocks/">www.benzinga.com/money/best-industrials-stocks/</a></li>
</ul>
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Movers

CAPT

CDTG

ELPW

EOSE

HIHO

NEPH

PFAI

SGLY

WETO

12 Industrials Stocks Moving In Thursday's Intraday Session

<h3>Gainers</h3>
<ul>
<li>Babcock &amp; Wilcox Enterprises, Inc. 6.50% Senior Notes due 2026 (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BWNB#NYSE">BWNB</a>) shares increased by 8.8% to $7.9 during Thursday's after-market session. </li>
<li>TTEC Holdings (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TTEC#NASDAQ">TTEC</a>) shares increased by 8.49% to $4.34. The market value of their outstanding shares is at $207.4 million. As per the news, the Q1 earnings report came out today. </li>
<li>Lyft (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LYFT#NASDAQ">LYFT</a>) stock increased by 7.69% to $14.0. The company's market cap stands at $5.8 billion. The company's, Q1 earnings came out today. </li>
<li>PAMT (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PAMT#NASDAQ">PAMT</a>) shares moved upwards by 7.69% to $18.05. The company's market cap stands at $393.3 million. </li>
<li>Power Solutions Intl (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PSIX#NASDAQ">PSIX</a>) stock rose 7.2% to $29.75. The company's market cap stands at $684.4 million. </li>
<li>Nephros (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NEPH#NASDAQ">NEPH</a>) shares increased by 6.06% to $2.1. The market value of their outstanding shares is at $22.2 million. As per the press release, Q1 earnings came out today. </li>
</ul>
<h3>Losers</h3>
<ul>
<li>Solidion Technology (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/STI#NASDAQ">STI</a>) stock declined by 17.5% to $0.13 during Thursday's after-market session. The market value of their outstanding shares is at $17.6 million. </li>
<li>Flux Power Holdings (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/FLUX#NASDAQ">FLUX</a>) shares declined by 16.25% to $1.65. The company's market cap stands at $27.6 million. The company's, Q3 earnings came out today. </li>
<li>Safe &amp; Green Holdings (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SGBX#NASDAQ">SGBX</a>) stock decreased by 14.74% to $0.48. The company's market cap stands at $3.4 million. </li>
<li>Micropolis Hldgs (AMEX:<a class="ticker" href="https://www.benzinga.com/stock/MCRP#AMEX">MCRP</a>) stock fell 11.67% to $2.65. The company's market cap stands at $89.7 million. </li>
<li>New Century Logistics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NCEW#NASDAQ">NCEW</a>) stock fell 10.95% to $1.22. The market value of their outstanding shares is at $26.2 million. </li>
<li>Innodata (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/INOD#NASDAQ">INOD</a>) stock declined by 10.2% to $36.92. The market value of their outstanding shares is at $1.1 billion. As per the press release, Q1 earnings came out today. 
See Also: <a href="http://www.benzinga.com/money/best-industrials-stocks/" title="www.benzinga.com/money/best-industrials-stocks/">www.benzinga.com/money/best-industrials-stocks/</a></li>
</ul>
This article was generated by Benzinga's automated content engine and reviewed by an editor.

BWNB

FLUX

INOD

LYFT

MCRP

NCEW

PAMT

PSIX

SGBX

TTEC

12 Industrials Stocks Moving In Thursday's After-Market Session

Nephros (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NEPH#NASDAQ">NEPH</a>) reported quarterly earnings of $0.05 per share which beat the analyst consensus estimate of $(0.01) by 600 percent. This is a 350 percent increase over losses of $(0.02) per share from the same period last year. The company reported quarterly sales of $4.88 million which beat the analyst consensus estimate of $3.65 million by 33.56 percent. This is a 38.47 percent increase over sales of $3.52 million the same period last year.

Earnings

Earnings Beats

News

Nephros Q1 EPS $0.05 Beats $(0.01) Estimate, Sales $4.88M Beat $3.65M Estimate

AAOI

ABCL

ABEV

ACIC

ACIW

ACMR

ACTG

AFRM

AKAM

AKBA

ALGM

ALIT

ALRM

ALXO

Amplify YieldShares Oil Hedged MLP Income ETF

AMLX

AMPX

AMTX

APPN

APYX

AQMS

ARGX

ARHS

ARKO

ARLO

ASPN

ASTH

Adtalem Global Education Inc. Common Stock

ATGE

ATHM

ATUS

AUTL

AVAH

AVPT

AXGN

BAER

BBDC

BIGC

BILL

BIRD

BlackSky Technology Inc. Class A Common Stock

BKSY

BLFS

BLND

CARG

CARS

CBLL

CBUS

CCEC

CCOI

CCRD

CDTX

CION

CLAR

CLFD

CLNE

CLSK

CMPS

CMRE

CODX

COIN

COLD

COLL

COMP

CRNX

CRON

CROX

CRVS

CTEV

CTKB

CTLP

CVRX

DAVE

DCGO

DCTH

DIOD

DKNG

Earnings Scheduled For May 8, 2025

WIIM

AGCO

Shares of machinery companies are trading higher amid ongoing volatility, possibly related to tariff delays.

Benchmark analyst Robert Wasserman reiterates Nephros (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NEPH#NASDAQ">NEPH</a>) with a Speculative Buy and maintains $5 price target.

Price Target

Reiteration

Analyst Ratings

Benchmark Reiterates Speculative Buy on Nephros, Maintains $5 Price Target

Nephros (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NEPH#NASDAQ">NEPH</a>) reported quarterly earnings of $0.02 per share which beat the analyst consensus estimate of $(0.02) by 200 percent. The company reported quarterly sales of $3.500 million which beat the analyst consensus estimate of $3.499 million by 0.03 percent. This is a 6.47 percent decrease over sales of $3.742 million the same period last year.

Nephros Q3 2024 GAAP EPS $0.02 Beats $(0.02) Estimate, Sales $3.500M Beat $3.499M Estimate

Nephros (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NEPH#NASDAQ">NEPH</a>) reported quarterly sales of $3.50 million which met the analyst consensus estimate. This is a 6.47 percent decrease over sales of $3.74 million the same period last year.

Nephros Q3 Sales $3.50M Inline

Nephros (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NEPH#NASDAQ">NEPH</a>) reported quarterly losses of $(0.03) per share which missed the analyst consensus estimate of $(0.01) by 200 percent. This is a 25 percent increase over losses of $(0.04) per share from the same period last year. The company reported quarterly sales of $3.25 million which missed the analyst consensus estimate of $3.86 million by 15.75 percent. This is a 8.27 percent decrease over sales of $3.54 million the same period last year.

Nephros Q2 EPS $(0.03) Misses $(0.01) Estimate, Sales $3.25M Miss $3.86M Estimate

The Dow Jones index closed lower by over 300 points on Thursday. When insiders purchase or sell shares, it indicates their confidence or concern around the company&#8217;s prospects. Investors and traders interested in penny stocks can consider this a factor in their overall investment or trading decision.
Below is a look at a few recent notable insider transactions for penny stocks. For more, check out <a href="https://www.benzinga.com/sec/insider-trades/">Benzinga&#8217;s insider transactions</a> platform.
<h3 class="wp-block-heading">Nephros</h3>
<ul>
<li>The Trade: Nephros, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NEPH#NASDAQ">NEPH</a>) Director Arthur H Amron <a href="https://www.benzinga.com/sec/insider-trades/">bought a total of 5,000 shares</a> at an average price of $2.24. To acquire these shares, it cost around $11,176.</li>
<li>What's Happening: On May 9, Nephros posted a narrower-than-expected quarterly loss.</li>
<li>What Nephros Does: Nephros Inc is a commercial-stage company that develops and sells high-performance water solutions to the medical and commercial markets.</li>
</ul>
<h3 class="wp-block-heading">Presidio Property Trust</h3>
<ul>
<li>The Trade: Presidio Property Trust, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SQFT#NASDAQ">SQFT</a>) CEO Jack Kendrick Heilbron <a href="https://www.benzinga.com/sec/insider-trades/">acquired a total of 10,300 shares </a> at an average price of $0.80. To acquire these shares, it cost around $8,257.</li>
<li>What's Happening: On May 14, the company said net loss for the three months ended March 31, 2024 was approximately $5.8 million, or 47 cents per basic and diluted share.</li>
<li>What Presidio Property Trust Does: Presidio Property Trust Inc is an internally managed, diversified REIT with holdings in model home properties which are triple-net leased to homebuilders, office, industrial, and retail properties.</li>
</ul>
<h3 class="wp-block-heading">GEE Group</h3>
<ul>
<li>The Trade: GEE Group Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/JOB#NYSE">JOB</a>) Director John Randall Waterfield <a href="https://www.benzinga.com/sec/insider-trades/">acquired a total of 250,000 shares</a> at an average price of $0.36. The insider spent around $89,831 to buy those shares. </li>
<li>What's Happening: On May 15, GEE Group posted weaker-than-expected quarterly sales.</li>
<li>What GEE Group Does: GEE Group Inc is a provider of specialized staffing solutions across the United States.</li>
</ul>
Read More: <a href="https://www.benzinga.com/news/24/05/39085305/top-4-materials-stocks-you-may-want-to-dump-in-q2">Top 4 Materials Stocks You May Want To Dump In Q2</a>

Long Ideas

Penny Stocks

Pre-Market Outlook

Markets

Trading Ideas

SQFT

GEE Group And 2 Other Stocks Under $3 Insiders Are Buying

Offerings

Nephros Files For Mixed Shelf Of Up To $50M

Nephros (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NEPH#NASDAQ">NEPH</a>) reported quarterly losses of $(0.02) per share which beat the analyst consensus estimate of $(0.04) by 50 percent. This is a 33.33 percent increase over losses of $(0.03) per share from the same period last year. The company reported quarterly sales of $3.522 million which missed the analyst consensus estimate of $3.734 million by 5.68 percent. This is a 4.73 percent decrease over sales of $3.697 million the same period last year.

Earnings Misses

Nephros Q1 2024 GAAP EPS $(0.02) Beats $(0.04) Estimate, Sales $3.522M Miss $3.734M Estimate

Benchmark analyst Robert Wasserman upgrades Nephros (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NEPH#NASDAQ">NEPH</a>) from Hold to Speculative Buy and announces $5 price target.

Upgrades

Benchmark Upgrades Nephros to Speculative Buy, Announces $5 Price Target

Nephros (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NEPH#NASDAQ">NEPH</a>) reported its Q4 earnings results on Thursday, March 7, 2024 at 04:15 PM.
Here's what investors need to know about the announcement.
<h3>Earnings</h3>
Nephros missed estimated earnings by -200.0%, reporting an EPS of $-0.06 versus an estimate of $-0.02.
Revenue was up $742 thousand from the same period last year.
<h3>Past Earnings Performance</h3>
Last quarter the company beat on EPS by $0.04 which was followed by a 3.0% drop in the share price the next day.
Here's a look at Nephros's past performance:

<table>
<thead>
<tr>
<th>Quarter</th>
<th>Q3 2023</th>
<th>Q2 2023</th>
<th>Q1 2023</th>
<th>Q4 2022</th>
</tr>
</thead>
<tbody>
<tr>
<td>EPS Estimate</td>
<td>-0.06</td>
<td>-0.05</td>
<td>-0.02</td>
<td>-0.06</td>
</tr>
<tr>
<td>EPS Actual</td>
<td>-0.02</td>
<td>-0.04</td>
<td>-0.03</td>
<td>-0.07</td>
</tr>
<tr>
<td>Revenue Estimate</td>
<td>3.35M</td>
<td>3.11M</td>
<td>3.68M</td>
<td>2.80M</td>
</tr>
<tr>
<td>Revenue Actual</td>
<td>3.74M</td>
<td>3.54M</td>
<td>3.70M</td>
<td>2.56M</td>
</tr>
</tbody>
</table>

To track all earnings releases for Nephros <a href="https://www.benzinga.com/quote/NEPH/earnings">visit their earnings calendar here.</a> 
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Nephros: Q4 Earnings Insights

Nephros (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NEPH#NASDAQ">NEPH</a>) reported quarterly losses of $(0.060) per share which missed the analyst consensus estimate of $(0.030) by 100 percent. The company reported quarterly sales of $3.300 million which missed the analyst consensus estimate of $3.813 million by 13.47 percent. This is a 29.01 percent increase over sales of $2.558 million the same period last year.

Nephros Q4 2023 GAAP EPS $(0.060) Misses $(0.030) Estimate, Sales $3.300M Miss $3.813M Estimate

Comments

Nephros

空売り

Nephros (NASDAQ:NEPH) 株価情報, 空売り情報

こんな人も見ています

ニュース

パートナーシップ

ベンジンガ・グローバル